I think they going to be closer to $5 on 1% of the market, if Japan is selling for $70 and making a profit and covering all costs.
Even if sales are $680 ( which the company indicated they would be likely be above ) per month per patient, and you said US cost was double the JDM for manufacture / sales / transport etc... so only $500 profit per unit. ( or 134 million in costs for 338 million in sales)
That gives Aus market cap of 6.7 Billion ... or $4.20 per share with PE 20:1
Sofdra - Post approval royalties, costs and earnings, page-30
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.8¢ |
Change
-0.008(2.63%) |
Mkt cap ! $444.9M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.8¢ | $802.7K | 2.850M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 1325310 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 103007 | 6 |
View Market Depth
| Last trade - 13.05pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
28.0¢ |
Change
-0.008 ( 1.62 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 29.0¢ | 28.0¢ | 1528281 | ||
| Last updated 13.23pm 05/06/2024 ? | |||||
| BOT (ASX) Chart |